Annual Drug Patent Expirations for NOXAFIL
Noxafil is a drug marketed by Merck Sharp Dohme, Schering, and Msd Merck Co and, and is included in four NDAs. It is available from three suppliers. There are seven patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for NOXAFIL.
This drug has eigthy-nine patent family members in twenty-one countries.
The generic ingredient in NOXAFIL is posaconazole. Three suppliers are listed for this compound. Additional details are available on the posaconazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
